Immunofluorescence mapping for the diagnosis of epidermolysis bullosa

35Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Immunofluorescence mapping is based on the detection of structural proteins of keratinocytes or of the dermo-epidermal junction using specific poly- or monoclonal antibodies. Through this method, the level of split formation can be determined by investigating the location of a given antigen in a natural or induced blister. This method also allows testing for the normal expression, reduction or absence of various structural proteins depending on the antibodies used. It has widely replaced transmission electron microscopy and is used as the initial laboratory test to prove the clinical diagnosis of epidermolysis bullosa. © 2010 Elsevier Inc.

Cite

CITATION STYLE

APA

Pohla-Gubo, G., Cepeda-Valdes, R., & Hintner, H. (2010, April). Immunofluorescence mapping for the diagnosis of epidermolysis bullosa. Dermatologic Clinics. https://doi.org/10.1016/j.det.2009.12.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free